Bristol-Myers Parts Ways With Mead Johnson

03/18/2010 05:12 am ET | Updated May 25, 2011

As the end of the year rapidly approaches Bristol-Myers Squibb (BMY) is making some last-minute adjustments to its financial forecast. The Big Pharma company said Wednesday that it was lowering its guidance for the full-year 2009. Excluding one-time charges the company now expects earnings to be $1.75 to $1.80 a share compared with a previous range of $2.00 to $2.05. Analysts surveyed by Thomson Reuters had expected on average earnings of $2.02 per share. The last-minute update to the company’s annual earnings forecast reflects the completion of its spin off of consumer children’s health care products-maker Mead Johnson Nutrition ...

Read more on Minyanville


Suggest a correction